申请人:Ajinomoto Co., Inc.
公开号:EP1839661A2
公开(公告)日:2007-10-03
The present invention discloses a composition containing a component that is an in vivo intrinsic substance and widely-consumed. The present invention provides a composition containing pipecolic acid in its provided amount of 20mg/kg to 2000mg/kg of body weight per day. The composition of the present invention can be used, for example, in the treatment of diabetes.
本发明公开了一种含有一种成分的组合物,该成分是一种体内固有物质,被广泛食用。本发明提供了一种含有哌啶醇酸的组合物,其规定用量为每天 20 毫克/千克至 2000 毫克/千克体重。本发明的组合物可用于治疗糖尿病等。